Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sander

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
FEBS Letters|June 29, 2016
Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged swordKatja Becker, Peter Sander
Frontiers in Microbiology|September 28, 2018
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in <i>Mycobacterium abscessus</i> Drug ResistanceSakshi Luthra, Anna Rominski, Peter Sander
BMC Microbiology|October 8, 2013
Lipoproteins of slow-growing Mycobacteria carry three fatty acids and are N-acylated by apolipoprotein N-acyltransferase BCG_2070cJuliane K Brülle, Andreas Tschumi, Peter Sander
Cell Chemical Biology|September 24, 2016
Lipase Processing of Complex Lipid AntigensPeter Sander, Katja Becker, Michael Dal Molin
Plos One|April 25, 2012
A β-Lactamase based reporter system for ESX dependent protein translocation in mycobacteriaTobias Rosenberger, Juliane K Brülle, Peter Sander
BMC Microbiology|July 19, 2008
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutantPeter M Keller, Erik C Böttger, Peter Sander
Microbiology (Reading, England)|February 27, 2007
Lipoprotein synthesis in mycobacteriaMandana Rezwan, Thomas Grau, Andreas Tschumi, et al.
Pharmacoeconomics|November 5, 2003
Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of diseaseRoger Jones, Silke Horbach, Peter Sander, et al.
Journal of Microbiological Methods|July 15, 2006
Breaking down the wall: fractionation of mycobacteriaMandana Rezwan, Marie-Antoinette Lanéelle, Peter Sander, et al.
European Journal of Gastroenterology & Hepatology|February 16, 2007
Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE studyKhean-Lee Goh, Robert Benamouzig, Peter Sander, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
FEBS Letters|June 29, 2016
Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged swordKatja Becker, Peter Sander
Frontiers in Microbiology|September 28, 2018
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in <i>Mycobacterium abscessus</i> Drug ResistanceSakshi Luthra, Anna Rominski, Peter Sander
BMC Microbiology|October 8, 2013
Lipoproteins of slow-growing Mycobacteria carry three fatty acids and are N-acylated by apolipoprotein N-acyltransferase BCG_2070cJuliane K Brülle, Andreas Tschumi, Peter Sander
Cell Chemical Biology|September 24, 2016
Lipase Processing of Complex Lipid AntigensPeter Sander, Katja Becker, Michael Dal Molin
Plos One|April 25, 2012
A β-Lactamase based reporter system for ESX dependent protein translocation in mycobacteriaTobias Rosenberger, Juliane K Brülle, Peter Sander
BMC Microbiology|July 19, 2008
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutantPeter M Keller, Erik C Böttger, Peter Sander
Microbiology (Reading, England)|February 27, 2007
Lipoprotein synthesis in mycobacteriaMandana Rezwan, Thomas Grau, Andreas Tschumi, et al.
Pharmacoeconomics|November 5, 2003
Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of diseaseRoger Jones, Silke Horbach, Peter Sander, et al.
Journal of Microbiological Methods|July 15, 2006
Breaking down the wall: fractionation of mycobacteriaMandana Rezwan, Marie-Antoinette Lanéelle, Peter Sander, et al.
European Journal of Gastroenterology & Hepatology|February 16, 2007
Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE studyKhean-Lee Goh, Robert Benamouzig, Peter Sander, et al.
Pageof 10